UBS Cuts Price Target on Ecolab to $260 From $276, Keeps …

Q: What is the price target for Ecolab (ECL)?

The latest price target for Ecolab ( NYSE: ECL) was reported by Seaport Global on January 8, 2024. The analyst firm set a price target for $0.00 expecting ECL to fall to within 12 months (a possible -100.00 % downside ). 41 analyst firms have reported ratings in the last year. What is the most recent analyst rating for Ecolab (ECL)?

Q: Why has UBS downgraded Regeneron Pharmaceuticals Inc (regn) to 'neutral'?

Investing.com -- UBS has downgraded Regeneron Pharmaceuticals Inc (NASDAQ: REGN) to "Neutral" from "Buy" given uncertainty around its key Eylea franchise. Brokerage slashed price target to $738 from $1130. The brokerage highlighted limited adoption of high-dose Eylea amid rising branded and biosimilar competition.

Q: How often should you get a rating for Ecolab?

Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ecolab was filed on January 8, 2024 so you should expect the next rating to be made available sometime around January 8, 2025.

Q: Is Regeneron a good fit for UBS?

While Regeneron’s pipeline holds promise in obesity and severe food allergies, UBS flagged long development timelines and the need for proof-of-concept data. Near-term upside from these programs remains limited.

Q: What happened to Eylea price target?

Brokerage slashed price target to $738 from $1130. The brokerage highlighted limited adoption of high-dose Eylea amid rising branded and biosimilar competition. UBS projects a 14% drop in Eylea revenue for 2025, with further declines in 2026.

6 days ago · UBS Cuts Price Target on Ecolab to $260 From $276, Keeps Neutral Rating January 10, 2025 at 10:32 am EST Share This article is reserved for members ... UBS Cuts Price …

$260
OFF

UBS Cuts Price Target On Ecolab To $260 From $276, Keeps …

2 weeks from now

6 days ago · UBS Cuts Price Target on Ecolab to $260 From $276, Keeps Neutral Rating January 10, 2025 at 10:32 am EST Share This article is reserved for members ... UBS Cuts Price …

marketscreener.com

$276.00
OFF

UBS Downgrades Ecolab Shares To Neutral, Cuts Price Target On …

2 weeks from now

Nov 4, 2024 · On Monday, UBS adjusted its stance on Ecolab Inc . (NYSE: ECL) shares, shifting the rating from Buy to Neutral and setting a new price target of $276.00.The firm's decision …

investing.com

$300
OFF

Ecolab Inc.: Target Price Consensus And Analysts …

2 weeks from now

Jefferies Cuts Price Target on Ecolab to $300 From $310, Keeps Buy Rating MT Dec. 18 ... UBS Downgrades Ecolab to Neutral From Buy With $276 Price Target Nov. 04: MT ... BMO Capital …

marketscreener.com

$276
OFF

Ecolab Downgraded To Neutral From Buy At UBS - Markets Insider

2 weeks from now

Nov 4, 2024 · UBS downgraded Ecolab to Neutral from Buy with an unchanged price target of $276.The firm sees less potential for outsized stock gains, and views the stock’s risk/reward …

businessinsider.com

$276.00
OFF

UBS Downgrades Ecolab Shares To Neutral, Cuts Price Target On …

2 weeks from now

Nov 4, 2024 · On Monday, UBS adjusted its stance on Ecolab Inc . (NYSE: ECL) shares, shifting the rating from Buy to Neutral and setting a new price target of $276.00.The firm's decision …

investing.com

$260
OFF

UBS Cuts Price Target On Ecolab To $260 From $276, Keeps …

2 weeks from now

6 days ago · -- Ecolab has an average rating of overweight and mean price target of $278.50, according to analysts polled by FactSet. Price: 230.21, Change: -4.36, Percent Change: -1.86 ...

marketscreener.com

$259
OFF

Ecolab (NYSE:ECL) Stock, Analyst Ratings, Price Targets, Forecasts

2 weeks from now

Ecolab Inc has a consensus price target of $259.2 based on the ratings of 23 analysts. ... 2024 when UBS changed their price target from $276 to $276 for Ecolab Inc. Q.

benzinga.com

$276
OFF

UBS Maintains Buy On Ecolab, Lowers Price Target To $276

2 weeks from now

UBS Maintains Buy on Ecolab, Lowers Price Target to $276. Company Profile < Back. Share this news. ... RBC Capital Reiterates Outperform on Ecolab, Maintains $260 Price Target. 21 Aug …

capedge.com

$276.00
OFF

UBS Group Cuts Ecolab (NYSE:ECL) Price Target To $276.00

2 weeks from now

Aug 18, 2024 · Read UBS Group Cuts Ecolab (NYSE:ECL) Price Target to $276.00 at American Banking and Market News. Ecolab (NYSE:ECL – Free Report) had its target price reduced by …

americanbankingnews.com

$276
OFF

UBS Downgrades Ecolab To Neutral, Maintains Price Target To $276

2 weeks from now

Nov 4, 2024 · UBS analyst Joshua Spector downgrades Ecolab (NYSE:ECL) from Buy to Neutral and maintains the price target from $276 to $276.

sahmcapital.com

$300
OFF

Ecolab Price Target Raised To $300 From $260 At Barclays

2 weeks from now

Nov 18, 2024 · Barclays raised the firm’s price target on Ecolab (ECL) to $300 from $260 and keeps an Overweight rating on the shares after meeting with management. The firm says the …

nasdaq.com

$276
OFF

UBS Maintains Buy On Ecolab, Lowers Price Target To $276

2 weeks from now

Aug 15, 2024 · UBS analyst Joshua Spector maintains Ecolab (NYSE:ECL) with a Buy and lowers the price target from $288 to $276.

sahmcapital.com

$260
OFF

Ecolab Well-Positioned For Future Growth, Faces Short-Term …

2 weeks from now

6 days ago · UBS Cuts Price Target on Ecolab to $260 From $276, Keeps Neutral Rating MT Summary Quotes Charts Technical Analysis Static Chart ... UBS Cuts Price Target on Ecolab …

marketscreener.com

$276
OFF

UBS Downgrades Ecolab To Neutral From Buy With $276 Price Target

2 weeks from now

Nov 4, 2024 · -- Ecolab has an average outperform rating and price target range of $215 to $310, according to analysts polled by Capital IQ. Price: 245.19, Change: +0.62, Percent Change: …

marketscreener.com

$276.00
OFF

UBS Group Cuts Ecolab (NYSE:ECL) Price Target To $276.00

2 weeks from now

Aug 18, 2024 · Read UBS Group Cuts Ecolab (NYSE:ECL) Price Target to $276.00 at ETF Daily News. ... Free Report) had its target price reduced by UBS Group from $288.00 to $276.00 in …

etfdailynews.com

$260
OFF

BMO Capital Upgrades Ecolab To Outperform From Market …

2 weeks from now

Dec 17, 2024 · UBS Cuts Price Target on Ecolab to $260 From $276, Keeps Neutral Rating MT Summary Quotes Charts Technical Analysis Static Chart ... UBS Cuts Price Target on Ecolab …

marketscreener.com

$270
OFF

Piper Sandler Cuts Price Target On Ecolab To $270 From $305, …

2 weeks from now

Jan 7, 2025 · UBS Cuts Price Target on Ecolab to $260 From $276, Keeps Neutral Rating MT Summary Quotes Charts Technical Analysis Static Chart ... UBS Cuts Price Target on Ecolab …

marketscreener.com

FAQs about UBS Cuts Price Target on Ecolab to $260 From $276, Keeps … Coupon?

What is the price target for Ecolab (ECL)?

The latest price target for Ecolab ( NYSE: ECL) was reported by Seaport Global on January 8, 2024. The analyst firm set a price target for $0.00 expecting ECL to fall to within 12 months (a possible -100.00 % downside ). 41 analyst firms have reported ratings in the last year. What is the most recent analyst rating for Ecolab (ECL)? ...

Why has UBS downgraded Regeneron Pharmaceuticals Inc (regn) to 'neutral'?

Investing.com -- UBS has downgraded Regeneron Pharmaceuticals Inc (NASDAQ: REGN) to "Neutral" from "Buy" given uncertainty around its key Eylea franchise. Brokerage slashed price target to $738 from $1130. The brokerage highlighted limited adoption of high-dose Eylea amid rising branded and biosimilar competition. ...

How often should you get a rating for Ecolab?

Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ecolab was filed on January 8, 2024 so you should expect the next rating to be made available sometime around January 8, 2025. ...

Is Regeneron a good fit for UBS?

While Regeneron’s pipeline holds promise in obesity and severe food allergies, UBS flagged long development timelines and the need for proof-of-concept data. Near-term upside from these programs remains limited. ...

What happened to Eylea price target?

Brokerage slashed price target to $738 from $1130. The brokerage highlighted limited adoption of high-dose Eylea amid rising branded and biosimilar competition. UBS projects a 14% drop in Eylea revenue for 2025, with further declines in 2026. ...